Literature DB >> 4348181

Augmentation of drug-induced blood pressure increases in rats by amorbarbital.

R Buńag, P Mullenix.   

Abstract

The effects of amobarbital anaesthesia on blood pressure responses to angiotensin and noradrenaline were determined in rats with chronically implanted venous and aortic catheters. Responses were tested twice on the same day in each rat, first in the conscious state and then during anaesthesia. Blood pressure rises produced by noradrenaline and angiotensin were larger when the rats were anaesthetized with amobarbital than when they were conscious. This enhancement was not characteristic of general anaesthesia since urethane, instead of enhancing, depressed the pressor responses.Blockade of acetylcholine receptors with atropine also increased the response to pressor drugs. However, amobarbital in anaesthetic doses did not affect the response to acetylcholine, indicating that removal of compensatory parasympathetic reflexes was not a major cause of its enhancing effect. The effects of amobarbital on arterial pressure and heart rate were similar to those of the ganglion blocking drug pentolinium. When pressor responses were increased by amobarbital, autonomic ganglia were depressed as indicated by the loss of the response to nicotine. These findings suggest that amobarbital enhances blood pressure responses to noradrenaline and angiotensin by blocking autonomic ganglia.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4348181      PMCID: PMC1666504          DOI: 10.1111/j.1476-5381.1972.tb08149.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Mechanisms by which ganglioplegics and atropine enhance cardiovascular responsiveness.

Authors:  I H PAGE; J W McCUBBIN
Journal:  Am J Physiol       Date:  1963-07

2.  Depression of autonomic ganglia by barbiturates.

Authors:  K A EXLEY
Journal:  Br J Pharmacol Chemother       Date:  1954-06

3.  Increased cardiovascular reactivity caused by depletion of endogenous renin in dogs.

Authors:  R D Bunag; J W McCubbin; I H Page
Journal:  Circ Res       Date:  1968-12       Impact factor: 17.367

4.  Pressor effects of the tail-cuff method in awake normotensive and hypertensive rats.

Authors:  R D Buñag
Journal:  J Lab Clin Med       Date:  1971-10

5.  Lack of correlation between direct and indirect measurements of arterial pressure in unanaesthetized rats.

Authors:  R D Buñag; J W McCubbin; I H Page
Journal:  Cardiovasc Res       Date:  1971-01       Impact factor: 10.787

  5 in total
  7 in total

1.  Unsuitability of urethane anesthetized rats for testing potential beta-adrenoreceptor blockers.

Authors:  C A Maggi; A Meli
Journal:  Experientia       Date:  1982-04-15

2.  The effect of urethane on histamine-induced contraction of guinea-pig tracheal smooth muscle.

Authors:  C A Maggi; P Santicioli; S Evangelista; A Meli
Journal:  Experientia       Date:  1982-12-15

Review 3.  Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: Cardiovascular system.

Authors:  C A Maggi; A Meli
Journal:  Experientia       Date:  1986-03-15

4.  Cardiovascular responses to noradrenaline in the rat before and after administration of various anaesthetics.

Authors:  H E Brezenoff
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

5.  The effects of pentobarbitone and urethane on pulmonary airway resistance in guinea-pigs and their interactions with drugs.

Authors:  C Advenier; J R Boissier; S Ho; B Mallard; F Ruff
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

6.  Urethane and contraction of vascular smooth muscle.

Authors:  B M Altura; J Weinberg
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

7.  Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist.

Authors:  R Couture; R Kérouac
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.